Somatic evolutionary timings of driver mutations
A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tu...
Saved in:
Published in | BMC cancer Vol. 18; no. 1; pp. 85 - 10 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.01.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses.
To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions.
While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers.
The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. |
---|---|
AbstractList | A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. Background A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. Methods To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. Results While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. Conclusions The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. Keywords: Driver mutation, Ubiquitous mutation, Private mutation, Somatic mutation Abstract Background A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses. Methods To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions. Results While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers. Conclusions The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers. |
ArticleNumber | 85 |
Audience | Academic |
Author | Gomez, Karen Kumar, Sudhir Miura, Sayaka Huuki, Louise A Townsend, Jeffrey P Spell, Brianna S |
Author_xml | – sequence: 1 givenname: Karen surname: Gomez fullname: Gomez, Karen organization: Department of Biology, Temple University, Philadelphia, PA, 19122, USA – sequence: 2 givenname: Sayaka surname: Miura fullname: Miura, Sayaka organization: Department of Biology, Temple University, Philadelphia, PA, 19122, USA – sequence: 3 givenname: Louise A surname: Huuki fullname: Huuki, Louise A organization: Institute for Genomics and Evolutionary Medicine, Sudhir Kumar, SERC 602A, 1925 N. 12th Street, Philadelphia, PA, 19122, USA – sequence: 4 givenname: Brianna S surname: Spell fullname: Spell, Brianna S organization: Department of Biology, Temple University, Philadelphia, PA, 19122, USA – sequence: 5 givenname: Jeffrey P surname: Townsend fullname: Townsend, Jeffrey P organization: Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, 06511, USA – sequence: 6 givenname: Sudhir surname: Kumar fullname: Kumar, Sudhir email: s.kumar@temple.edu, s.kumar@temple.edu, s.kumar@temple.edu organization: Center for Genomic Medicine and Research, King Abdulaziz University, Jeddah, Saudi Arabia. s.kumar@temple.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29347918$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1r3DAQhkVJaT7aH9BLWSgUenCqkWx9XAohpO1CoNC0ZzG2JK-CbQXLu2T_fbVxGtZQdJCYeebVSPOek5MhDo6Q90AvAZT4koApVRUUZMG1lMX-FTmDUkLBSipPjs6n5Dyle5pBRdUbcso0L6UGdUboXexxCs3K7WK3nUIccNyvptCHoU2r6Fd2DDs3rvrthIdsektee-ySe_e8X5A_325-X_8obn9-X19f3RaNEHwqwFJV85p5ZIJyz6VolGJWAbXCVYIzbWsBQmsFlgtfcga2qVACcCtsBfyCrGddG_HePIyhz42ZiME8BeLYGhxz450zKJAioq4rZKXmtPaq9MC8rpTQVvms9XXWetjWvbONG6YRu4XoMjOEjWnjzlRSllDSLPBxFmgx3xcGHzPW9CE15qpiXPKSCZWpy_9QeVnXhyaPzoccXxR8XhRkZnKPU4vblMz67teS_XTEbhx20yY9jywtQZjBZowpjc6_vBOoOdjGzLYx2Q3mYBuzzzUfjj_opeKfT_hfaMy83A |
CitedBy_id | crossref_primary_10_1038_s41598_024_63468_z crossref_primary_10_1186_s12862_020_01647_y crossref_primary_10_1093_molbev_msy091 crossref_primary_10_3390_ijerph15081791 crossref_primary_10_1016_j_csbj_2023_07_018 crossref_primary_10_1093_oncolo_oyad206 crossref_primary_10_1038_s43018_019_0002_1 crossref_primary_10_1126_science_aah6266 crossref_primary_10_1038_s41592_020_01013_2 crossref_primary_10_3389_fonc_2019_00952 crossref_primary_10_1158_0008_5472_CAN_21_0146 crossref_primary_10_1371_journal_pone_0215838 crossref_primary_10_4155_fdd_2019_0031 crossref_primary_10_1016_j_jmoldx_2022_09_006 crossref_primary_10_7124_bc_000AAA crossref_primary_10_1093_molbev_msz242 crossref_primary_10_1186_s13058_023_01635_2 crossref_primary_10_1242_dmm_039578 crossref_primary_10_1080_15384047_2022_2033058 crossref_primary_10_1093_molbev_msy079 |
Cites_doi | 10.1007/s00439-016-1670-x 10.1158/0008-5472.CAN-15-1889 10.1126/science.959840 10.1002/ijc.30437 10.1016/j.ccell.2014.12.001 10.1038/ncomms14114 10.1038/ng.3489 10.1056/NEJMoa1113205 10.1038/labinvest.2015.131 10.1371/journal.pgen.1005778 10.1186/s13039-017-0333-5 10.1093/nar/gku1075 10.1073/pnas.0801523105 10.1126/science.1256930 10.1101/gr.151670.112 10.1038/ng.3602 10.18632/oncotarget.1537 10.1158/0008-5472.CAN-15-3476 10.1186/s12885-015-1077-4 10.1038/nbt.3391 10.1371/journal.pgen.1005075 10.1002/path.4230 10.1038/nrg.2017.8 10.1038/nmeth.2642 10.1126/science.1239947 10.1093/bioinformatics/bts168 10.1073/pnas.1525677113 10.1038/oncsis.2015.34 10.1038/nature14347 10.1002/cncr.30430 10.1101/gr.180612.114 10.1182/blood-2012-09-457283 10.1186/s13059-014-0453-8 10.1038/ng.2764 10.18632/oncotarget.3111 10.1016/j.cell.2012.04.023 10.1038/ng.3343 10.1038/nm.3886 10.1038/nature05610 10.1093/nar/gkv1157 10.1038/ng.2291 10.1038/nature07943 10.1126/scitranslmed.aaa1408 10.1186/2047-217X-1-12 10.1038/ng.2891 10.1534/genetics.111.133975 10.1093/hmg/ddv177 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 BioMed Central Ltd. The Author(s). 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: The Author(s). 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 5PM DOA |
DOI | 10.1186/s12885-017-3977-y |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Science PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_a6a0aaa9b5a24930bf84f12f95869d8f A523734268 10_1186_s12885_017_3977_y 29347918 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NLM NIH HHS grantid: R01 LM012487 – fundername: NLM NIH HHS grantid: R21 LM012758 – fundername: U.S. National Library of Medicine grantid: LM012758 – fundername: U.S. National Library of Medicine grantid: LM012487 – fundername: ; grantid: LM012487; LM012758 |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO 5PM |
ID | FETCH-LOGICAL-c663t-1d08b3b2fa2603f376c882d810d6e56329db6169981d36f4321dc5a7113d6d513 |
IEDL.DBID | RPM |
ISSN | 1471-2407 |
IngestDate | Tue Oct 22 15:16:56 EDT 2024 Tue Sep 17 21:02:53 EDT 2024 Tue Nov 19 21:23:05 EST 2024 Tue Nov 12 23:20:51 EST 2024 Thu Aug 01 20:13:32 EDT 2024 Tue Aug 20 22:07:14 EDT 2024 Thu Sep 12 17:02:16 EDT 2024 Sat Nov 02 12:05:18 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Driver mutation Somatic mutation Private mutation Ubiquitous mutation |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c663t-1d08b3b2fa2603f376c882d810d6e56329db6169981d36f4321dc5a7113d6d513 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774140/ |
PMID | 29347918 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a6a0aaa9b5a24930bf84f12f95869d8f pubmedcentral_primary_oai_pubmedcentral_nih_gov_5774140 gale_infotracmisc_A523734268 gale_infotracacademiconefile_A523734268 gale_incontextgauss_ISR_A523734268 gale_healthsolutions_A523734268 crossref_primary_10_1186_s12885_017_3977_y pubmed_primary_29347918 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-18 |
PublicationDateYYYYMMDD | 2018-01-18 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cancer |
PublicationTitleAlternate | BMC Cancer |
PublicationYear | 2018 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | N McGranahan (3977_CR12) 2015; 7 WS Hong (3977_CR43) 2015; 75 JG Reiter (3977_CR39) 2017; 8 M Gerlinger (3977_CR6) 2012; 366 LR Yates (3977_CR26) 2015; 21 MJ Williams (3977_CR46) 2016; 48 D Ryu (3977_CR1) 2016; 135 DE Newburger (3977_CR15) 2013; 23 JY Lee (3977_CR30) 2015; 15 G Gundem (3977_CR31) 2015; 520 C Greenman (3977_CR40) 2007; 446 JN Weinstein (3977_CR9) 2013; 45 PC Nowell (3977_CR11) 1976; 194 R Uchi (3977_CR27) 2016; 12 ZM Zhao (3977_CR32) 2016; 113 MR Stratton (3977_CR5) 2009; 458 LL Zhang (3977_CR17) 2017; 140 3977_CR34 C Hiley (3977_CR4) 2014; 15 M Mehine (3977_CR19) 2015; 24 SA Forbes (3977_CR35) 2015; 43 BE Johnson (3977_CR24) 2014; 343 AB Kroigard (3977_CR23) 2015; 6 3977_CR37 MT Chang (3977_CR36) 2016; 34 J Zhang (3977_CR14) 2014; 346 WJ Gibson (3977_CR28) 2016; 48 A Youn (3977_CR7) 2012; 28 N McGranahan (3977_CR10) 2015; 27 MD Stachler (3977_CR29) 2015; 47 L Chen (3977_CR42) 2015; 11 A Bashashati (3977_CR16) 2013; 231 MR Green (3977_CR22) 2013; 121 A Gonzalez-Perez (3977_CR38) 2013; 10 H Kim (3977_CR25) 2015; 25 B Liu (3977_CR44) 2013; 4 PJ Campbell (3977_CR3) 2008; 105 A Fujimoto (3977_CR41) 2012; 44 R Yao (3977_CR45) 2017; 10 S Nik-Zainal (3977_CR8) 2012; 149 EA Mroz (3977_CR2) 2017; 123 KM Hardiman (3977_CR20) 2016; 96 Y Li (3977_CR48) 2012; 1 M Gerlinger (3977_CR13) 2014; 46 CJ Illingworth (3977_CR47) 2011; 189 K Harbst (3977_CR21) 2016; 76 A Yates (3977_CR33) 2016; 44 W Cao (3977_CR18) 2015; 4 |
References_xml | – volume: 135 start-page: 635 year: 2016 ident: 3977_CR1 publication-title: Hum Genet doi: 10.1007/s00439-016-1670-x contributor: fullname: D Ryu – volume: 75 start-page: 4021 year: 2015 ident: 3977_CR43 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-1889 contributor: fullname: WS Hong – volume: 194 start-page: 23 year: 1976 ident: 3977_CR11 publication-title: Science doi: 10.1126/science.959840 contributor: fullname: PC Nowell – volume: 140 start-page: 103 year: 2017 ident: 3977_CR17 publication-title: Int J Cancer doi: 10.1002/ijc.30437 contributor: fullname: LL Zhang – volume: 27 start-page: 15 year: 2015 ident: 3977_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccell.2014.12.001 contributor: fullname: N McGranahan – volume: 8 start-page: 14114 year: 2017 ident: 3977_CR39 publication-title: Nat Commun doi: 10.1038/ncomms14114 contributor: fullname: JG Reiter – volume: 48 start-page: 238 year: 2016 ident: 3977_CR46 publication-title: Nat Genet doi: 10.1038/ng.3489 contributor: fullname: MJ Williams – volume: 366 start-page: 883 year: 2012 ident: 3977_CR6 publication-title: N Engl J Med doi: 10.1056/NEJMoa1113205 contributor: fullname: M Gerlinger – volume: 96 start-page: 4 year: 2016 ident: 3977_CR20 publication-title: Lab Investig doi: 10.1038/labinvest.2015.131 contributor: fullname: KM Hardiman – volume: 12 start-page: e1005778 year: 2016 ident: 3977_CR27 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1005778 contributor: fullname: R Uchi – volume: 10 start-page: 30 year: 2017 ident: 3977_CR45 publication-title: Mol Cytogenet doi: 10.1186/s13039-017-0333-5 contributor: fullname: R Yao – volume: 43 start-page: D805 year: 2015 ident: 3977_CR35 publication-title: Nucleic Acids Res doi: 10.1093/nar/gku1075 contributor: fullname: SA Forbes – volume: 105 start-page: 13081 year: 2008 ident: 3977_CR3 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0801523105 contributor: fullname: PJ Campbell – volume: 346 start-page: 256 year: 2014 ident: 3977_CR14 publication-title: Science doi: 10.1126/science.1256930 contributor: fullname: J Zhang – volume: 23 start-page: 1097 year: 2013 ident: 3977_CR15 publication-title: Genome Res doi: 10.1101/gr.151670.112 contributor: fullname: DE Newburger – volume: 48 start-page: 848 year: 2016 ident: 3977_CR28 publication-title: Nat Genet doi: 10.1038/ng.3602 contributor: fullname: WJ Gibson – volume: 4 start-page: 1868 issue: 11 year: 2013 ident: 3977_CR44 publication-title: Oncotarget doi: 10.18632/oncotarget.1537 contributor: fullname: B Liu – volume: 76 start-page: 4765 year: 2016 ident: 3977_CR21 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-3476 contributor: fullname: K Harbst – volume: 15 start-page: 85 year: 2015 ident: 3977_CR30 publication-title: BMC Cancer doi: 10.1186/s12885-015-1077-4 contributor: fullname: JY Lee – volume: 34 start-page: 155 year: 2016 ident: 3977_CR36 publication-title: Nat Biotechnol doi: 10.1038/nbt.3391 contributor: fullname: MT Chang – volume: 11 start-page: e1005075 year: 2015 ident: 3977_CR42 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1005075 contributor: fullname: L Chen – volume: 231 start-page: 21 year: 2013 ident: 3977_CR16 publication-title: J Pathol doi: 10.1002/path.4230 contributor: fullname: A Bashashati – ident: 3977_CR34 – ident: 3977_CR37 doi: 10.1038/nrg.2017.8 – volume: 10 start-page: 1081 year: 2013 ident: 3977_CR38 publication-title: Nat Methods doi: 10.1038/nmeth.2642 contributor: fullname: A Gonzalez-Perez – volume: 343 start-page: 189 year: 2014 ident: 3977_CR24 publication-title: Science doi: 10.1126/science.1239947 contributor: fullname: BE Johnson – volume: 28 start-page: 1555 year: 2012 ident: 3977_CR7 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts168 contributor: fullname: A Youn – volume: 113 start-page: 2140 year: 2016 ident: 3977_CR32 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1525677113 contributor: fullname: ZM Zhao – volume: 4 start-page: e175 year: 2015 ident: 3977_CR18 publication-title: Oncogene doi: 10.1038/oncsis.2015.34 contributor: fullname: W Cao – volume: 520 start-page: 353 year: 2015 ident: 3977_CR31 publication-title: Nature doi: 10.1038/nature14347 contributor: fullname: G Gundem – volume: 123 start-page: 917 year: 2017 ident: 3977_CR2 publication-title: Cancer doi: 10.1002/cncr.30430 contributor: fullname: EA Mroz – volume: 25 start-page: 316 year: 2015 ident: 3977_CR25 publication-title: Genome Res doi: 10.1101/gr.180612.114 contributor: fullname: H Kim – volume: 121 start-page: 1604 year: 2013 ident: 3977_CR22 publication-title: Blood doi: 10.1182/blood-2012-09-457283 contributor: fullname: MR Green – volume: 15 start-page: 453 year: 2014 ident: 3977_CR4 publication-title: Genome Biol doi: 10.1186/s13059-014-0453-8 contributor: fullname: C Hiley – volume: 45 start-page: 1113 year: 2013 ident: 3977_CR9 publication-title: Nat Genet doi: 10.1038/ng.2764 contributor: fullname: JN Weinstein – volume: 6 start-page: 5634 year: 2015 ident: 3977_CR23 publication-title: Oncotarget doi: 10.18632/oncotarget.3111 contributor: fullname: AB Kroigard – volume: 149 start-page: 994 year: 2012 ident: 3977_CR8 publication-title: Cell doi: 10.1016/j.cell.2012.04.023 contributor: fullname: S Nik-Zainal – volume: 47 start-page: 1047 year: 2015 ident: 3977_CR29 publication-title: Nat Genet doi: 10.1038/ng.3343 contributor: fullname: MD Stachler – volume: 21 start-page: 751 year: 2015 ident: 3977_CR26 publication-title: Nat Med doi: 10.1038/nm.3886 contributor: fullname: LR Yates – volume: 446 start-page: 153 year: 2007 ident: 3977_CR40 publication-title: Nature doi: 10.1038/nature05610 contributor: fullname: C Greenman – volume: 44 start-page: D710 year: 2016 ident: 3977_CR33 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1157 contributor: fullname: A Yates – volume: 44 start-page: 760 year: 2012 ident: 3977_CR41 publication-title: Nat Genet doi: 10.1038/ng.2291 contributor: fullname: A Fujimoto – volume: 458 start-page: 719 year: 2009 ident: 3977_CR5 publication-title: Nature doi: 10.1038/nature07943 contributor: fullname: MR Stratton – volume: 7 start-page: 283ra254 year: 2015 ident: 3977_CR12 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaa1408 contributor: fullname: N McGranahan – volume: 1 start-page: 12 year: 2012 ident: 3977_CR48 publication-title: Gigascience doi: 10.1186/2047-217X-1-12 contributor: fullname: Y Li – volume: 46 start-page: 225 year: 2014 ident: 3977_CR13 publication-title: Nat Genet doi: 10.1038/ng.2891 contributor: fullname: M Gerlinger – volume: 189 start-page: 989 issue: 3 year: 2011 ident: 3977_CR47 publication-title: Genetics doi: 10.1534/genetics.111.133975 contributor: fullname: CJ Illingworth – volume: 24 start-page: 4407 year: 2015 ident: 3977_CR19 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddv177 contributor: fullname: M Mehine |
SSID | ssj0017808 |
Score | 2.366772 |
Snippet | A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation,... Background A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer... Abstract Background A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of... |
SourceID | doaj pubmedcentral gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 85 |
SubjectTerms | Analysis Base Sequence - genetics Carcinogenesis - genetics Clonal Evolution - genetics Development and progression DNA sequencing Driver mutation Genetic aspects Genetic Heterogeneity Growth Humans Mutation Mutation - genetics Neoplasms - genetics Neoplasms - pathology Private mutation Sequence Analysis, DNA Somatic mutation Tumors Ubiquitous mutation |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIb9dnEUEQikmTpslRxWUV1oO6sLeQNo16sCvbXWH_vZM2W8zJi9dmDs03ycw3zCMIXRjwYlobHWPDaMyYJK5ZOYtzllpw0BKXzPUOD5_4YMQex-n411NfriasHQ_cAnetucZaa5mnGiIFinMrmCWJlang0gjbWF-cLIMpnz_IBBY-h0kEv67BCgtXpAYXCghPvAi8UDOsvzPJnSMKiyR_eZ3-JtrwdDG6aX9zC62U1TZaG_qE-A7CL5Nm5mpUfvszpKeLaOae6nqro4mNzNQVXkSf8zblXu-iUf_-9W4Q-0cQ4gJgnMXEYJHTPLEaIg9qwR4UQIqNINjwMuU0kSbnhEPURAzlltGEmCLVGSHUcJMSuodWq0lVHqCIkkLSwgLJkZgVoIi8zAzPEsx1CZGM7aGrJSjqq511oZoYQXDVIqgAQeUQVIseunWwdYJuTHXzAZSnvPLUX8rroTMHump7PrvLpm4gPM4okAfRQ-eNhBtVUblamDc9r2v18PIcCF16ITsBXRXatxbAtt10q0DyOJCEu1QEy_ut0rttARtimSSwkgXHIdh3uFJ9vDdjulNg1hC-Hv4HUEdoHZiaKzuMiThGq7PpvDwBNjTLT5uD_wOIzwVE priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA9zA_Fl6Py6Ol0RQRCqSZPm42GMKRvb4PrgvLC3kDbNVXCttveK97_3JM2qgT342hza5uScnN_hfCH02oIVM8aaHFtGc8YU8cXKIq9Y6cBAK9wwXzs8_8TPFuziqrzaQjfjrSIDh1tdOz9PatF_f_f75-YIFP4wKLzk7we4Y6VPQQN1ATiTb-6gnQIMo8_wmrO_QQUhw4A6AvexDyqIGOS89RWJmQrd_Kc7e7JUaRblP2bp9D7ajXgyOx4F4AHaato9dHceI-YPEb7sQlPWrPkVhcz0m2zlZ3kth6xzme19ZkZ2vR5j8sMjtDg9-fLxLI9TEvIa-LzKicWyolXhDLgm1MGFUQNqtpJgy5uS00LZihMObhWxlDtGC2Lr0ghCqOW2JPQx2m67tnmKMkpqRWsHKEhhVsNJVY2wXBSYmwZcHTdDb2-Yon-MzTB0cCIk1yMHNXBQew7qzQx98GybCH0f6_Cg65c6qoU23GBjjKpKA34gxZWTzJHCqVJyZSV88cAzXY9FoZM26mPwnwUFdCFn6FWg8L0sWp8sszTrYdDnl58TojeRyHVwVrWJtQewbd_-KqHcTyhB2epk-cl46NO2AC4xoQisiEQckn2nK-23r6GPdwnQG_zbZ__9c8_RPcBrPvkwJ3Ifba_6dfMCMNGqehkk_Q-_AAWQ priority: 102 providerName: Scholars Portal |
Title | Somatic evolutionary timings of driver mutations |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29347918 https://pubmed.ncbi.nlm.nih.gov/PMC5774140 https://doaj.org/article/a6a0aaa9b5a24930bf84f12f95869d8f |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJDqWX0ne3TVNTCoWCs5Ily9IxCQ1pYUtJGgi9CD2sTaBrh_VuYf99R7Js4msvOthjbM2MNDOemU8IfXJgxbR2OseO0ZwxSUKzcpUbVnow0BLXLPQOL37wi2v2_aa82UPl0AsTi_atuTtu_qyOm7vbWFt5v7LzoU5s_nNxVoLPAoHBfB_tg_kdQvSUOqgEFil9SQSfd7ABi1CfBmsJfJ18F-B_ZeifDOd8PLBFEbJ_3JhHczQtlXxge86foifJacxO-o97hvbq5jl6tEhp8RcIX7UReTWr_yZN0utdtgkHdi27rPWZW4fyi2y17RPv3Ut0ff7119lFno5CyC0wc5MTh4WhpvAa4g_qYVew4Bo7QbDjdclpIZ3hhEPsRBzlntGCOFvqihDquCsJfYUOmrap36CMEiup9eDqSMwsiMPUleNVgbmuIZ7xM_RlYIq67xEvVIwUBFc9MxUwUwVmqt0MnQa2jYQBrDpeaNdLlUSmNNdYay1NqSHYo9h4wTwpvCwFl07AGz8Epqu-83NccuoEguSKggshZuhjpAiAFU2oiFnqbdepb1eXE6LPici3ICurU4MBTDtgXE0oDyeUsKLs5PbrXujjtAaFmaFqog6TeU_vgO5GsO6kq2__-8l36DE4aaHiMCfiEB1s1tv6PThCG3MUfyDAuGACxsvT30dxKfwDezQIHw |
link.rule.ids | 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpCm0voc9007QxpVAoOCtZliwd09CwabOhNAnkJmTJ2ga6dljvFvbfdyTLJr72ao2xNQ_NN8xDCH2y4MW0tjrFNqdpnkvim5WLtMyZAwctcZX73uH5JZ_d5N9v2e0OYn0vTCjaN-Xdcf1neVzf_Q61lfdLM-3rxKY_56cMMAsEBtNH6DGjhSR9kB6TB4XAIiYwieDTFo5g4SvUwJoA7aRbPwBY-g5Kf9PHA28UhvYPR_PgkMbFkg-8z9lztBdhY3LS_d4LtFPVL9GTeUyMv0L4qgmzV5Pqb9Qlvdoma39l16JNGpfYlS_ASJabLvXevkY3Z9-uT2dpvAwhNcDOdUosFiUtM6chAqEOzgUD4NgKgi2vGKeZtCUnHKInYil3Oc2INUwXhFDLLSP0Ddqtm7p6ixJKjKTGAdiRODcgkLIqLC8yzHUFEY2boC89U9R9N_NChVhBcNUxUwEzlWem2k7QV8-2gdCPqw4PmtVCRaEpzTXWWsuSaQj3KC6dyB3JnGSCSyvgi0ee6arr_RyMTp1AmFxQABFigj4GCj-yovY1MQu9aVt1fvVrRPQ5ErkGZGV0bDGAbfspVyPKwxEl2JQZLe93Qh-21SvMBBUjdRjte7wC2hvGdUdtPfjvN4_Q09n1_EJdnF_-eIeeAWTz9YcpEYdod73aVO8BFq3LD8EI_gHpiwiW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSBMviG8Kg0UICQkpix3Hjv04BtUGdJoYk_ZmOXZcJtGkalqk_vecHTdqXnmNL0p8d_b9TveF0AcLVkxrq1NsC5oWhSS-WLlMq4I5MNAS14WvHZ5d8vOb4tstu90b9RWS9k11d9L8WZw0d79DbuVyYbJdnlh2NTtjgFnAMciW1mX30QNGQcl2jnoMIJQCixjEJIJnHVzDwmepwYkCxJNufRNg6aso_bSPPYsUGvcP1_NglMYJk3sWaPoYPYrQMTntf_EJulc3T9HhLAbHnyF83Yb-q0n9N-qTXm2TtR_bNe-S1iV25ZMwksWmD793z9HN9Ouvs_M0DkRIDbB0nRKLRUWr3GnwQqiDu8EAQLaCYMtrxmkubcUJBw-KWMpdQXNiDdMlIdRyywh9gQ6atqlfoYQSI6lxAHgkLgwIpapLy8scc12DV-Mm6NOOKWrZ971QwV8QXPXMVMBM5ZmpthP02bNtIPQtq8ODdjVXUXBKc4211rJiGlw-iisnCkdyJ5ng0gr44rFnuurrP4eDp07BVS4pAAkxQe8DhW9b0fi8mLnedJ26uP45IvoYiVwLsjI6lhnAtn2nqxHl0YgSzpUZLb_shT5sa6cwE1SO1GG07_EKaHBo2R019vV_v3mMDq--TNWPi8vvb9BDQG0-BTEl4ggdrFeb-i0go3X1LpyBf8BsCak |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Somatic+evolutionary+timings+of+driver+mutations&rft.jtitle=BMC+cancer&rft.au=Gomez%2C+Karen&rft.au=Miura%2C+Sayaka&rft.au=Huuki%2C+Louise+A&rft.au=Spell%2C+Brianna+S&rft.date=2018-01-18&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-017-3977-y&rft.externalDocID=A523734268 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |